Functionalizing Hydroxyapatite With Proadhesive Peptides
Functionalizing Hydroxyapatite With Proadhesive Peptides
批准号:
7125118
负责人:
Susan L Bellis
金额:
$25.01万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-22 至 2009-08-31
关键词:
biomaterial evaluationbiomaterial interface interactionbiomimeticsbiotechnologybone morphogenetic proteinscalcium phosphatecell adhesioncell differentiationcollagengene expressionhuman tissuehydroxyapatiteslaboratory ratmesenchymeosteogenesispeptidesprotein bindingprotein engineeringprotein structure functionstem cellssurface coatingtissue /cell culture
中文摘要
描述(由申请人提供):每年,数百万美国人接受某种类型的矫形或牙科种植。关节假体(例如髋关节和膝关节)在恢复患者功能方面非常成功,然而这些装置通常只能使用10-15年。用于填补骨缺损或损伤的植入物甚至更不发达;目前治疗的“金标准”是自体骨移植,它有许多相关的风险和局限性。最近,许多研究人员试图通过用模拟内源性骨环境的分子修饰生物材料来改善植入物的性能,例如,从细胞外基质成分中提取的肽。这种“仿生学方法”在增强某些类型材料的生物活性方面显示出了很大的希望,然而,令人惊讶的是,磷酸钙这种最具骨导电性的材料在这方面受到的关注最少。为了解决生物材料研究中的这一缺陷,该项目的广泛、长期目标是确定模拟蛋白/肽,如胶原l源肽和骨形态发生蛋白-2 (BMP-2),是否可以增强磷酸钙生物材料的骨整合,特别是羟基磷灰石(HA)。为了实现这一目标,我们设计了4个具体目标:
英文摘要
DESCRIPTION (provided by applicant): Every year, millions of Americans receive some type of orthopaedic or dental implant. Joint prostheses (e.g. hip and knee) have been very successful in restoring function to patients, however these devices generally last only 10-15 years. Implants used for filling bone defects or lesions are even less well-developed; the current "gold standard" for treatment is autologous bone graft, which carries many associated risks and limitations. Recently, many investigators have sought to improve implant performance by modifying biomaterials with molecules that mimic the endogenous bone environment, for example, peptides derived from components of the extracellular matrix. This "biomimetics approach" has shown much promise for enhancing the bioactivity of certain types of materials, however, surprisingly, the class of materials that is among the most osseoconductive, the calcium phosphates, has received the least amount of attention in this regard. To address this deficit in biomaterials research, the broad, long-term goal of this project is to determine whether mimetic proteins/peptides, such as collagen l-derived peptides and Bone Morphogenic Protein-2 (BMP-2), can enhance the osseointegration of calcium phosphate biomaterials, particularly hydroxyapatite (HA). To accomplish this goal, we have designed 4 specific aims:
Specific Aim 1: To identify biomimetic peptides that stimulate optimal in vitro human mesenchymal stem cell (MSC) attachment and differentiation.
Specific Aim 2: To determine whether engineering peptides with additional domains enhances peptide tethering and/or bioactivity. More specifically, peptides will be modified by adding an HA-binding sequence, or by inserting a polylinker domain between the HA- and cell-binding motifs.
Specific Aim 3: To test the efficacy of peptide coatings in promoting adhesion and differentiation of endogenous MSCs, leading to enhanced bone formation. A rat tibial implantation model will be used to test peptide efficacy in vivo.
Specific Aim 4: To determine whether osseointegration can be improved by pre-loading scaffolds with MSCs. Public-health relatedness: The major goal of this study is to optimize the performance of calcium phosphate biomaterials that are commonly used for joint prosthetic and bone replacement applications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sialylation-dependent mechanisms driving pancreatic cancer progression
-
批准号:10468125
-
项目类别:
-
资助金额:$50.37万
-
财政年份:2018
-
负责人:Susan L Bellis
-
依托单位:
Sialylation-dependent mechanisms driving pancreatic cancer progression
-
批准号:10242715
-
项目类别:
-
资助金额:$52.28万
-
财政年份:2018
-
负责人:Susan L Bellis
-
依托单位:
Glycan control of stem cell-associated pathways in pancreatic cancer
-
批准号:8986782
-
项目类别:
-
资助金额:$15.99万
-
财政年份:2015
-
负责人:Susan L Bellis
-
依托单位:
Coupling osteoinductive factors to graft materials to promote osteoregeneration
-
批准号:8782796
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2014
-
负责人:Susan L Bellis
-
依托单位:
Glycosylation-dependent mechanisms regulating ovarian tumor cell survival
-
批准号:9042398
-
项目类别:
-
资助金额:$27.93万
-
财政年份:2014
-
负责人:Susan L Bellis
-
依托单位:
Glycosylation-dependent mechanisms regulating ovarian tumor cell phenotype
-
批准号:10376286
-
项目类别:
-
资助金额:$31.11万
-
财政年份:2014
-
负责人:Susan L Bellis
-
依托单位:
Coupling osteoinductive factors to graft materials to promote osteoregeneration
-
批准号:9110953
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2014
-
负责人:Susan L Bellis
-
依托单位:
Glycosylation-dependent mechanisms regulating ovarian tumor cell survival
-
批准号:8718244
-
项目类别:
-
资助金额:$27.93万
-
财政年份:2014
-
负责人:Susan L Bellis
-
依托单位:
Glycosylation-dependent mechanisms regulating ovarian tumor cell phenotype
-
批准号:10590617
-
项目类别:
-
资助金额:$31.11万
-
财政年份:2014
-
负责人:Susan L Bellis
-
依托单位:
Functionalizing Hydroxyapatite With Proadhesive Peptides
-
批准号:7280963
-
项目类别:
-
资助金额:$24.28万
-
财政年份:2005
-
负责人:Susan L Bellis
-
依托单位:
Functionalizing Hydroxyapatite With Proadhesive Peptides
-
批准号:7033173
-
项目类别:
-
资助金额:$27.81万
-
财政年份:2005
-
负责人:Susan L Bellis
-
依托单位:
Functionalizing Hydroxyapatite With Proadhesive Peptides
-
批准号:7473246
-
项目类别:
-
资助金额:$23.8万
-
财政年份:2005
-
负责人:Susan L Bellis
-
依托单位:
Regulation of beta1 integrin glycosylation by ras
-
批准号:7623604
-
项目类别:
-
资助金额:$24.48万
-
财政年份:2002
-
负责人:Susan L Bellis
-
依托单位:
Regulation of B1 Integrin Glycosylation by RAS
-
批准号:6692148
-
项目类别:
-
资助金额:$23.86万
-
财政年份:2002
-
负责人:Susan L Bellis
-
依托单位:
Regulation of beta1 integrin glycosylation by ras
-
批准号:7842694
-
项目类别:
-
资助金额:$24.48万
-
财政年份:2002
-
负责人:Susan L Bellis
-
依托单位:
Regulation of B1 Integrin Glycosylation by RAS
-
批准号:6434135
-
项目类别:
-
资助金额:$23.61万
-
财政年份:2002
-
负责人:Susan L Bellis
-
依托单位:
Regulation of beta1 integrin glycosylation by ras
-
批准号:7463871
-
项目类别:
-
资助金额:$24.48万
-
财政年份:2002
-
负责人:Susan L Bellis
-
依托单位:
Regulation of B1 Integrin Glycosylation by RAS
-
批准号:6621392
-
项目类别:
-
资助金额:$23.86万
-
财政年份:2002
-
负责人:Susan L Bellis
-
依托单位:
Regulation of beta1 integrin glycosylation by ras
-
批准号:8078107
-
项目类别:
-
资助金额:$23.75万
-
财政年份:2002
-
负责人:Susan L Bellis
-
依托单位:
Regulation of B1 Integrin Glycosylation by RAS
-
批准号:7058271
-
项目类别:
-
资助金额:$23.3万
-
财政年份:2002
-
负责人:Susan L Bellis
-
依托单位: